Oncolytic Virus Therapies Market Size to Reach USD 970 Million by 2031 | Straits Research

The global Oncolytic Virus Therapies Market was valued at USD 214 million in 2022 and is projected to reach USD 270.28 million in 2023, with an estimated value of USD 970 million by 2031. The market is expected to grow at a CAGR of 26.3% during the forecast period (2023–2031), driven by growing investments in cancer therapies and advancements in viral-based treatment methods.

Download Free Sample Report with Complimentary Analyst Consultation : https://straitsresearch.com/re....port/oncolytic-virus

Vaccines Market Trends & Forecast: USD 59.34 Billion by 2024 | Straits Research
The global Vaccines Market was valued at USD 55.82 billion in 2023 and is projected to reach USD 59.34 billion in 2024, with an estimated value of USD 96.90 billion by 2032. The market is expected to grow at a CAGR of 6.32% during the forecast period (2024–2032), driven by rising demand for immunization and advancements in vaccine technologies.

Download Free Sample Report with Complimentary Analyst Consultation : https://straitsresearch.com/re....port/vaccines-market

Cell Therapy Market to Reach USD 32,645.4 Million by 2031 | Straits Research

According to Straits Research, the global Cell Therapy Market was valued at USD 10,118.3 million in 2022 and is projected to grow from USD XX million in 2023 to USD 32,645.4 million by 2031, registering a CAGR of 13.9% during the forecast period (2023–2031). The market is witnessing significant expansion due to advancements in regenerative medicine, increasing prevalence of chronic diseases, and rising investments in cell-based research and development.

Download Free Sample Report with Complimentary Analyst Consultation : https://straitsresearch.com/re....port/cell-therapy-ma